| Marc A Albertson, PA-C | |
|
3288 Moanalua Rd, Honolulu, HI 96819-1469 | |
| (808) 432-0000 | |
| Not Available |
| Full Name | Marc A Albertson |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 19 Years |
| Location | 3288 Moanalua Rd, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003933078 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | AMD274 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital | Honolulu, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hawaii Permanente Medical Group Inc | 7618880667 | 541 |
News Archive
Merck reported today that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, demonstrated significantly higher sustained virologic response (SVR) rates in adult patients who previously failed treatment (treatment-failure; HCV RESPOND-2) and in adult patients who were new to treatment for chronic hepatitis C virus (HCV) genotype 1 compared to control, the primary objective of the studies.
AstraZeneca purchased a one-year membership to gain access to an international repository of data designed to aid industry and academic researchers developing new technologies to improve cardiac safety.
A new technology harnesses imperfections that typically compromise MRI exams to create images resolved enough to enable consistent diagnoses across populations for the first time.
The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc will launch extensions to its ACTICOAT(TM) Silver Coated Antimicrobial Barrier Dressing portfolio at the upcoming Symposium on Advanced Wound Care Spring meeting April 17-19, 2010, in Orlando, FL. The new dressings will be highlighted at the Smith & Nephew booth, #301.
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has entered into a research and exclusive license agreement with Teva Pharmaceutical Industries Ltd. to develop and commercialize XMT-1107, a novel fumagillin analog, for the treatment of all indications, including cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marc A Albertson, PA-C 3288 Moanalua Rd, Honolulu, HI 96819-1469 Ph: (808) 432-0000 | Marc A Albertson, PA-C 3288 Moanalua Rd, Honolulu, HI 96819-1469 Ph: (808) 432-0000 |
News Archive
Merck reported today that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, demonstrated significantly higher sustained virologic response (SVR) rates in adult patients who previously failed treatment (treatment-failure; HCV RESPOND-2) and in adult patients who were new to treatment for chronic hepatitis C virus (HCV) genotype 1 compared to control, the primary objective of the studies.
AstraZeneca purchased a one-year membership to gain access to an international repository of data designed to aid industry and academic researchers developing new technologies to improve cardiac safety.
A new technology harnesses imperfections that typically compromise MRI exams to create images resolved enough to enable consistent diagnoses across populations for the first time.
The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc will launch extensions to its ACTICOAT(TM) Silver Coated Antimicrobial Barrier Dressing portfolio at the upcoming Symposium on Advanced Wound Care Spring meeting April 17-19, 2010, in Orlando, FL. The new dressings will be highlighted at the Smith & Nephew booth, #301.
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has entered into a research and exclusive license agreement with Teva Pharmaceutical Industries Ltd. to develop and commercialize XMT-1107, a novel fumagillin analog, for the treatment of all indications, including cancer.
› Verified 7 days ago
Mandi Sue Breyman, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1329 Lusitana St Ste 202, Honolulu, HI 96813 Phone: -- | |
Ryan David Asencios, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 770 Kapiolani Blvd Ste 705, Honolulu, HI 96813 Phone: 808-597-8791 | |
Cody A. Shishido, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Nicole Evans, Physician Assistant Medicare: Medicare Enrolled Practice Location: 2230 Liliha St Ste 104, Honolulu, HI 96817 Phone: 808-261-4476 | |
Shaylee Jo Caulkins, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1401 S Beretania St Ste 102, Honolulu, HI 96814 Phone: 808-356-5699 | |
Timothy Quinn Howard, PHYSICIAN ASSISTANT Physician Assistant Medicare: Medicare Enrolled Practice Location: 1029 Kapahulu Ave Ste 503, Honolulu, HI 96816 Phone: 808-218-7889 Fax: 808-218-7891 |